QOL data deserve better reporting, standardised use

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.571, 2009-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Better QOL after PTCA for CAD

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 263, 2000-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

ICDs: better QOL than amiodarone in ventricular arrhythmias

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

QOL better with carboplatin + paclitaxel for ovarian cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 498, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Fluticasone: better QOL in bronchiectasis at higher doses

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Intermittent HAART no better than continuous for QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite